Trademark: 88204561
Status Date
Monday, August 29, 2022
Filing Date
Sunday, November 25, 2018
Published for Opposition
Tuesday, May 28, 2019
Abandoned Date
Monday, August 29, 2022
42 Pharmaceutical products development; Research and development in the field of oncology; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Research in the field of oncology; Research on the subject of pharmaceuticals; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Bacteriological research; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical, biochemical, biological and bacteriological research and analysis; Clinical research in the field of oncology; Compiling data for research purposes in the field of medical science and medical consultancy; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Laboratory research in the field of oncology; Laboratory research services relating to pharmaceuticals; Medical research; Medical and scientific research in the field of oncology; Medical and scientific research information in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research services in the field of cancer; Pharmaceutical research and development; Pharmaceutical research services; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical research and scientific research information in the field of oncology via the Internet; Providing medical testing services and information in the field of cancer research and disease classification; Scientific research; Scientific research and development; Scientific research consulting in the field of oncology; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer; Stem cell research services; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
SIGNAL ONE BIOTECHNOLOGY
"BIO"
Aug 29, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 29, 2022
Abandonment - No Use Statement Filed
Jan 8, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 7, 2022
Sou Extension 5 Granted
Jan 4, 2022
Sou Extension 5 Filed
Jan 4, 2022
Sou Teas Extension Received
Jul 21, 2021
Notice Of Approval Of Extension Request E-Mailed
Jul 19, 2021
Sou Extension 4 Granted
Jul 19, 2021
Sou Extension 4 Filed
Jul 19, 2021
Sou Teas Extension Received
Jun 10, 2021
Teas Change Of Correspondence Received
Jun 10, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 10, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 6, 2021
Notice Of Approval Of Extension Request E-Mailed
Mar 5, 2021
Sou Extension 3 Granted
Jan 25, 2021
Sou Extension 3 Filed
Mar 2, 2021
Notice Of Revival - E-Mailed
Mar 1, 2021
Sou Extension Received With Teas Petition
Mar 1, 2021
Petition To Revive-Granted
Mar 1, 2021
Teas Petition To Revive Received
Mar 1, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 1, 2021
Abandonment - No Use Statement Filed
Sep 1, 2020
Notice Of Approval Of Extension Request E-Mailed
Aug 31, 2020
Sou Extension 2 Granted
Jul 23, 2020
Sou Extension 2 Filed
Aug 25, 2020
Notice Of Revival - E-Mailed
Aug 24, 2020
Sou Extension Received With Teas Petition
Aug 24, 2020
Petition To Revive-Granted
Aug 24, 2020
Teas Petition To Revive Received
Aug 24, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 24, 2020
Abandonment - No Use Statement Filed
Mar 27, 2020
Notice Of Approval Of Extension Request E-Mailed
Mar 26, 2020
Sou Extension 1 Granted
Jan 23, 2020
Sou Extension 1 Filed
Mar 25, 2020
Case Assigned To Intent To Use Paralegal
Mar 2, 2020
Notice Of Revival - E-Mailed
Feb 29, 2020
Sou Extension Received With Teas Petition
Feb 29, 2020
Petition To Revive-Granted
Feb 29, 2020
Teas Petition To Revive Received
Feb 24, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 24, 2020
Abandonment - No Use Statement Filed
Jul 23, 2019
Noa E-Mailed - Sou Required From Applicant
Jul 22, 2019
Assigned To Examiner
May 28, 2019
Official Gazette Publication Confirmation E-Mailed
May 28, 2019
Published For Opposition
May 8, 2019
Notification Of Notice Of Publication E-Mailed
Apr 24, 2019
Law Office Publication Review Completed
Apr 22, 2019
Assigned To Lie
Apr 9, 2019
Approved For Pub - Principal Register
Feb 13, 2019
Teas/Email Correspondence Entered
Feb 12, 2019
Correspondence Received In Law Office
Feb 12, 2019
Teas Response To Office Action Received
Feb 1, 2019
Notification Of Non-Final Action E-Mailed
Feb 1, 2019
Non-Final Action E-Mailed
Feb 1, 2019
Non-Final Action Written
Jan 28, 2019
Assigned To Examiner
Dec 13, 2018
New Application Office Supplied Data Entered
Nov 28, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
